Equities analysts forecast that Imperva Inc (NYSE:IMPV) will report sales of $83.07 million for the current fiscal quarter, Zacks Investment Research reports. Seven analysts have issued estimates for Imperva’s earnings. The lowest sales estimate is $82.01 million and the highest is $83.80 million. Imperva reported sales of $68.41 million during the same quarter last year, which would suggest a positive year-over-year growth rate of 21.4%. The firm is expected to report its next quarterly earnings results after the market closes on Wednesday, November 8th.

On average, analysts expect that Imperva will report full-year sales of $83.07 million for the current fiscal year, with estimates ranging from $320.90 million to $324.02 million. For the next financial year, analysts anticipate that the company will post sales of $379.96 million per share, with estimates ranging from $369.00 million to $386.30 million. Zacks Investment Research’s sales calculations are an average based on a survey of sell-side research firms that that provide coverage for Imperva.

Imperva (NYSE:IMPV) last posted its quarterly earnings data on Thursday, July 27th. The software maker reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.05 by ($0.15). The company had revenue of $74.44 million during the quarter, compared to the consensus estimate of $74.30 million. Imperva had a negative net margin of 4.69% and a negative return on equity of 5.00%. The company’s revenue was up 28.6% on a year-over-year basis. During the same quarter last year, the business earned ($0.23) earnings per share.

Several equities research analysts have recently commented on IMPV shares. Monness Crespi & Hardt lifted their price target on shares of Imperva from $55.00 to $57.00 and gave the stock a “buy” rating in a research report on Friday, July 28th. Evercore ISI set a $56.00 price target on shares of Imperva and gave the stock a “buy” rating in a research report on Friday, July 28th. Piper Jaffray Companies set a $58.00 price target on shares of Imperva and gave the stock a “buy” rating in a research report on Monday, August 28th. BidaskClub cut shares of Imperva from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 5th. Finally, Royal Bank Of Canada reiterated a “buy” rating and set a $49.00 price target on shares of Imperva in a research report on Wednesday, October 18th. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and eleven have given a buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $51.37.

In other news, Director Anthony J. Bettencourt sold 99,598 shares of the business’s stock in a transaction on Thursday, August 24th. The shares were sold at an average price of $43.59, for a total value of $4,341,476.82. Following the sale, the director now owns 99,598 shares of the company’s stock, valued at $4,341,476.82. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Insiders own 2.20% of the company’s stock.

A number of hedge funds and other institutional investors have recently bought and sold shares of the business. Vanguard Group Inc. raised its position in Imperva by 4.3% during the second quarter. Vanguard Group Inc. now owns 2,439,240 shares of the software maker’s stock worth $116,718,000 after acquiring an additional 99,799 shares in the last quarter. BlackRock Inc. raised its position in Imperva by 11.3% during the second quarter. BlackRock Inc. now owns 2,124,043 shares of the software maker’s stock worth $101,635,000 after acquiring an additional 215,170 shares in the last quarter. Eagle Asset Management Inc. raised its position in Imperva by 17.7% during the second quarter. Eagle Asset Management Inc. now owns 1,279,848 shares of the software maker’s stock worth $61,240,000 after acquiring an additional 192,625 shares in the last quarter. Clearbridge Investments LLC raised its position in Imperva by 47.0% during the first quarter. Clearbridge Investments LLC now owns 1,262,507 shares of the software maker’s stock worth $51,826,000 after acquiring an additional 403,809 shares in the last quarter. Finally, ETF Managers Group LLC bought a new stake in Imperva during the second quarter worth $41,888,000. 92.72% of the stock is currently owned by hedge funds and other institutional investors.

Imperva (IMPV) traded down 0.34% on Tuesday, hitting $43.70. 85,143 shares of the stock traded hands. The stock’s market cap is $1.48 billion. Imperva has a 12-month low of $34.40 and a 12-month high of $52.40. The stock has a 50-day moving average price of $43.75 and a 200 day moving average price of $45.96.

ILLEGAL ACTIVITY WARNING: “$83.07 Million in Sales Expected for Imperva Inc (IMPV) This Quarter” was posted by American Banking News and is the property of of American Banking News. If you are reading this story on another site, it was illegally stolen and republished in violation of United States and international trademark and copyright legislation. The original version of this story can be viewed at https://www.americanbankingnews.com/2017/10/24/83-07-million-in-sales-expected-for-imperva-inc-impv-this-quarter.html.

About Imperva

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Get a free copy of the Zacks research report on Imperva (IMPV)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with MarketBeat.com's FREE daily email newsletter.